Nektar Therapeutics Balance Sheet - Annual (NASDAQ:NKTR)

Add to My Stocks
$19.39 $0.53 (2.81%) NKTR stock closing price Apr 25, 2017 (Closing)

A thorough fundamental analysis involves using data from Nektar Therapeutics balance sheet, apart from other financial statements, to value the business. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Nektar Therapeutics stock analysis. A company releases its balance sheet every quarter along with its quarterly results. Nektar Therapeutics balance sheet as at the end of 2016 indicates an asset turnover ratio of 0.3M and debt to equity ratio of 2.82M. Whereas, Nektar Therapeutics revenue was $165.43M and Nektar Therapeutics operating cash flow was $-117.02M for the same period. View latest and last 10 year balance sheet data to check Nektar Therapeutics financial performance..

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Cash59.64M55.57M37.36M39.06M25.43M15.31M17.75M49.59M155.58M76.29M
Marketable Securities329.46M253.37M225.45M197.95M251.75M225.85M298.17M346.61M223.41M406.06M
Receivables15.67M19.94M3.6M2.22M5.8M4.93M25.1M4.8M11.16M21.63M
Inventory11.1M11.34M12.95M13.45M18.26M12.65M7.26M6.47M9.31M12.18M
Raw Materials2.05M3.23M2.2M3.94M7.48M9.75M6.1M5.93M6.96M-
Work In Progress7.31M6.08M5.18M6.14M6.66M1.21M--1.74M-
Finished Goods1.74M2.02M5.56M3.35M4.11M1.68M1.16M0.53M0.61M-
Notes Receivable----------
Other Current Assets10.36M9.81M8.81M5.17M13.36M17.94M5.67M6.18M6.74M7.1M
Nektar Therapeutics Total Current Assets
426.25M350.05M288.2M257.88M314.63M276.7M353.97M413.66M406.22M523.28M
Property Plant & Equipment176.84M174.04M164.17M151.12M144.88M140.81M143.76M132.66M117.08M-
Accumulated Depreciation111.24M102.71M93.8M84.14M72.66M62.23M53.99M54.4M43.5M-
Nektar Therapeutics Net Property Plant & Equipment
65.6M71.33M70.36M66.97M72.21M78.57M89.77M78.26M73.57M114.42M
Investment & Advances-----173.76M----
Other Non-Current Assets----------
Deferred Charges----------
Intangibles76.5M76.5M76.5M76.5M76.5M76.5M76.5M76.5M76.5M81.11M
Deposits & Other Assets0.51M4.17M6.55M33.17M34.44M0.99M0.97M7.08M4.23M6.28M
Nektar Therapeutics Total Assets
568.87M502.06M441.62M434.52M497.79M606.55M521.22M575.51M560.53M725.1M
Notes Payable----------
Accounts Payable2.81M2.36M2.7M9.11M2.86M3.01M7.19M3.06M13.83M3.58M
Current Portion Long-Term Debt-----214.95M----
Current Portion Capital Leases2.9M4.75M4.51M------2.33M
Accrued Expenses35.14M22.57M26.79M44.31M41.36M31.42M29.93M28.57M39.11M70.2M
Income Taxes Payable----------
Other Current Liabilities31.35M31.55M30.04M44.78M34.31M26.12M26.97M121.37M15.42M21.96M
Nektar Therapeutics Total Current Liabilities
72.22M61.24M64.04M98.22M78.53M275.53M64.1M153.01M68.37M98.09M
Mortgages----------
Deferred Taxes/Income51.88M62.42M76.91M82.38M98.95M111.46M128.91M81.83M61.46M61.34M
Convertible Debt------214.95M214.95M214.95M315M
Long-Term Debt243.46M242.11M125M125M125M-----
Non-Current Capital Leases2.22M1.07M4.13M8.04M11.6M14.58M17.01M18.8M20.34M21.63M
Other Long-Term Liabilities110.95M128.77M135.19M210.77M136.67M7.15M5.57M4.54M5.23M14.59M
Nektar Therapeutics Total Liabilities
480.74M495.63M405.28M524.43M450.77M408.73M430.56M473.15M370.38M510.66M
Minority Interest----------
Preferred Stock----------
Common Stock Net0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Capital Surplus2.11B1.88B1.82B1.64B1.62B1.6B1.35B1.33B1.31B1.3B
Retained Earnings-2.02B-1.87B-1.79B-1.73B-1.57B-1.4B-1.26B-1.23B-1.12B-1.09B
Treasury Stock----------
Other Liabilities-2.36M-2.17M-1.56M-1.18M-0.35M-1.1M0.96M1.02M1.43M1.64M
Nektar Therapeutics Shareholders Equity
88.12M6.42M36.33M-89.9M47.01M197.81M90.66M102.36M190.15M214.43M
Nektar Therapeutics Total Liabilities & Shareholders Equity
568.87M502.06M441.62M434.52M497.79M606.55M521.22M575.51M560.53M725.1M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

1:22
NKTR
The latest Nektar Therapeutics stock price, and Nektar Therapeutics historical stock prices show the stock price movement over time, and the Nektar Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: Anything that the Nektar Therapeutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Nektar Therapeutics had total assets of $568.87M.
  • Liabilities: The total liabilities of Nektar Therapeutics for 2016 total to $480.74M. Liabilities for a company like Nektar Therapeutics include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.
.

Nektar Therapeutics Balance Sheet - Key Ratios

Current ratio
5.9
Debt to Equity ratio
2.82
Asset Turnover
ratio
0.3
receivables turnover
ratio
7.05
PB ratio (
price to book ratio
)
-1126.4490